Status:
RECRUITING
The TIOB - Collection of Patients' Biospecimens for Analysis of Immunological and Molecular Biomarkers.
Lead Sponsor:
Baylor Research Institute
Collaborating Sponsors:
Translational Genomics Research Institute
Conditions:
Cancer
Eligibility:
All Genders
Brief Summary
The purpose of the Texas Immuno-Oncology Biorepository (TIOB) is to collect and store well-defined and well-annotated serial biospecimens of tissue, blood, urine and stool in a longitudinal manner fro...
Detailed Description
The goal of establishing the Texas Immuno-Oncology Biorepository (TIOB) is to create a research facility that purposely consents patients to collect, catalog, process, store, and analyze biospecimens ...
Eligibility Criteria
Inclusion
- Understand and willingness to sign written informed consent method.
- Patients who are suspected by a physician of being at risk for developing cancer.
- Patients with confirmed or clinically suspected malignancy by a physician. This includes but is not limited to candidates for immunotherapy, surgical candidates, patients receiving Standard of Care drugs, immunotherapy drugs, participating on a clinical trial with immunotherapy drugs, patients who have received immunotherapy drugs in the past, patients with any other approved or investigational disease management.
Exclusion
- Patients unwilling to donate blood
- Patients unwilling to provide informed consent for the collection of fresh or archived tumor tissue.
Key Trial Info
Start Date :
September 11 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 11 2052
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT05371756
Start Date
September 11 2020
End Date
September 11 2052
Last Update
October 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Baylor Scott & White Research Institute
Dallas, Texas, United States, 75246